Sirtex Medical announced that the FDA has approved the company’s SIR-Spheres yttrium-90 (Y90) resin microspheres for the trea ...

Basis Medical announced the completion of the first-in-human clinical procedures using the company’s Seclusion catheter to t ...

Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical ...

BioStem Technologies, Inc., a developer of placental-derived products for wound care, recently announced that patient ...

Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG ...

Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention business of ...

Small saphenous vein (SSV) reflux is an important and often overlooked cause of superficial venous insufficiency. It is present in about one-sixth of patients with superficial venous insufficiency, ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Barostim Indications for Use Barostim is indicated for patients who are: New York Heart Association class III or class II (who had a recent history of class III) despite treatment with ...

Figure 1. The Artix Thrombectomy System includes an 8-F thin-walled sheath with a 7-F access profile, a covered funnel catheter for proximal flow restriction, the MT catheter with an expandable ...

More than 4 million patients worldwide have end-stage kidney disease, and in the United States, there are > 800,000 patients. Autogenous AVF is the preferred vascular access for patients who require ...